Chung Eric
Department of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland 4102, Australia.
AndroUrology Centre, Brisbane, Queensland 4000, Australia.
Bladder (San Franc). 2025 Jun 11;12(3):e21200051. doi: 10.14440/bladder.2025.0001. eCollection 2025.
Male lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement (BPE) represent a common urological condition, especially in older males. Literature supports a strong association between male LUTS/BPE and sexual dysfunction. While transurethral resection of the prostate is often considered the standard for male LUTS/BPE surgical treatment, it causes complications across various male sexual domains, such as erectile dysfunction and ejaculatory disorders. In recent years, there have been considerable advances in minimally invasive surgical treatments (MISTs) for male LUTS/BPE. Published literature has shown that MISTs can improve various parameters of voiding domains while minimizing adverse sexual effects.
This article provides an overview of the present understanding of the association between male LUTS/BPE and sexual dysfunction, and the present commercially available MISTs, with a specific focus on sexual function outcomes.
Present MISTs for male LUTS/BPE have demonstrated considerable improvements in various urinary parameters while minimizing adverse effects across different sexual function domains.
良性前列腺增生（BPE）继发的男性下尿路症状（LUTS）是一种常见的泌尿系统疾病，在老年男性中尤为常见。文献支持男性LUTS/BPE与性功能障碍之间存在密切关联。虽然经尿道前列腺切除术通常被认为是男性LUTS/BPE手术治疗的标准方法，但它会在男性性功能的各个方面引发并发症，如勃起功能障碍和射精障碍。近年来，男性LUTS/BPE的微创外科治疗（MIST）取得了长足进展。已发表的文献表明，MIST可以改善排尿领域的各项参数，同时将不良性影响降至最低。
本文概述了目前对男性LUTS/BPE与性功能障碍之间关联的认识，以及目前市面上可获得的MIST，特别关注性功能结果。
目前用于男性LUTS/BPE的MIST在各种排尿参数方面有显著改善，同时将不同性功能领域的不良影响降至最低。
